Detalles de la búsqueda
1.
Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial.
Lancet Oncol
; 13(2): 145-53, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22261362
2.
Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial.
J Clin Oncol
; 36(31): 3077-3083, 2018 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30016178
3.
[Bronchiolitis obliterans organizing pneumonia following radiotherapy]. / Bronchiolite oblitérante d'organisation pneumonique après radiothérapie.
Presse Med
; 34(7): 506-8, 2005 Apr 09.
Artículo
en Francés
| MEDLINE | ID: mdl-15903003
4.
Preliminary data of the GORTEC 2000-02 phase III trial comparing intravenous and subcutaneous administration of amifostine for head and neck tumors treated by external radiotherapy.
Semin Oncol
; 29(6 Suppl 19): 57-60, 2002 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-12577246
5.
Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study.
J Clin Oncol
; 31(7): 853-9, 2013 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23341517
6.
Subcutaneous compared with intravenous administration of amifostine in patients with head and neck cancer receiving radiotherapy: final results of the GORTEC2000-02 phase III randomized trial.
J Clin Oncol
; 29(2): 127-33, 2011 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-21115863
7.
Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation.
J Natl Cancer Inst
; 101(7): 498-506, 2009 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19318632
Resultados
1 -
7
de 7
1
Próxima >
>>